Literature DB >> 17037616

Comparison of cytogenetics and polymerase chain reaction based detection of the amelogenin gene polymorphism for the diagnosis of freemartinism in cattle.

Elizabeth A McNiel1, Nicole J Madrill, Amy E Treeful, Lance C Buoen, Alvin F Weber.   

Abstract

A polymerase chain reaction (PCR) assay which detects a sex-based polymorphism in the bovine amelogenin locus was modified and compared to conventional cytogenetic analysis for diagnosis of freemartinism (XX/XY chimerism) in cattle. The PCR assay is more sensitive than cytogenetic analysis for detection of XY cells, with the limit of detection of the assay falling between 0.2% and 1% XY cells. Seventy-three heifer blood samples submitted for evaluation of freemartinism to the University of Minnesota Diagnostic Laboratory were tested using both cytogenetic and PCR techniques. Poor-quality samples precluded successful lymphocyte culture and recovery of mitotic nuclei for cytogenetic evaluation in 17 cases (23%). Two of these samples (2.7%) also failed to amplify with PCR. There was 100% agreement in the results from the 56 samples that were suitable for testing using both techniques. This PCR-based assay provides an alternative to the more laborious cytogenetic evaluation for diagnosis of freemartinism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17037616     DOI: 10.1177/104063870601800508

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

1.  Application of polymerase chain reaction for fetal gender determination using cervical mucous secretions in the cow.

Authors:  Mohammad Reza Divar; Hassan Sharifiyazdi; Mojtaba Kafi
Journal:  Vet Res Commun       Date:  2012-08-03       Impact factor: 2.459

2.  Applying real-time quantitative PCR to diagnosis of freemartin in Holstein cattle by quantifying SRY gene: a comparison experiment.

Authors:  Qinghua Qiu; Taoqi Shao; Yang He; Aziz-Ur-Rahman Muhammad; Binghai Cao; Huawei Su
Journal:  PeerJ       Date:  2018-04-27       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.